SIEGEL TAVR: FIH 1 year & US Early Feasibility 30 Day Results
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker's Bureau - Edwards Lifesciences; Abbott; Boston Scientific Corporation
- Equity/Stock(s)/Options - DASI Simulations; Opus
- Advisory Board - Picardia; Trisol